STARKAGE THERAPEUTICS
Starkage Therapeutics is a discovery-stage biotechnology company. They also provide treatment for idiopathic pulmonary fibrosis, neurodegenerative diseases, and metabolic dysfunction or hepatic fibroses.
STARKAGE THERAPEUTICS
Industry:
Biotechnology Medical
Founded:
2018-01-01
Address:
Lille, Nord-Pas-de-Calais, France
Country:
France
Website Url:
http://www.starkagetx.com
Total Employee:
1+
Status:
Active
Contact:
+33 3 74 02 03 03
Email Addresses:
[email protected]
Total Funding:
3.2 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics LetsEncrypt
Investors List
Official Site Inspections
http://www.starkagetx.com
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Starkage Therapeutics"
StarkAge Therapeutics: a unique and relentless focus on senescence
StarkAge Therapeutics is a pioneering privately held discovery-stage biotechnology company based in Lille, France. It was founded by Dr. Thierry Mathieu, with scientific support from Dr. …See details»
Starkage Therapeutics - Crunchbase Company Profile & Funding
Organization. Starkage Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. About. ... Contact Email [email protected]; Phone …See details»
StarkAge Therapeutics - LinkedIn
StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases ...See details»
StarkAge Therapeutics - PitchBook
StarkAge Therapeutics General Information Description. Developer a biotechnology platform intended to improve the quality of life of patients. The company's platform specializes in …See details»
StarkAge Therapeutics - Precidiab
StarkAge Therapeutics is a privately-held, early-stage biotechnology company and pioneer in the field of senescence.Based in France in Lille, it was founded in 2018 by Dr. Thierry Mathieu on …See details»
StarkAge - 2025 Company Profile & Competitors - Tracxn
Apr 28, 2025 StarkAge - Developer of therapeutics to treat age-related diseases. StarkAge has 6 competitors.See details»
Senior Management - StarkAge Therapeutics
[email protected] +33 3 74 02 03 03; Toggle menu. Our Company. Senior Management; Scientific Advisory Board; Our Approach; News; Contact; Senior Management. StarkAge Therapeutics is lead by a team with strong and …See details»
StarkAge Therapeutics - Drug pipelines, Patents, …
Www.starkagetx.com. Startups | Holding Company | 2018 | France | < 10 | www.starkagetx.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The statistics for drugs in the Pipeline is the …See details»
StarkAge Therapeutics - VentureRadar
"StarkAge Therapeutics' ambition is to delay or halt disease progression and improve the quality of life of patients with age-related diseases associated with the accumulation of senescent …See details»
STARKAGE THERAPEUTICS - Societe.com
STARKAGE THERAPEUTICS, société par actions simplifiée, au capital social de 388600,00 EURO, dont le siège social est situé au 1 RUE DU PROFESSEUR CALMETTE, 59800 LILLE, …See details»
Starkage Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Starkage Therapeutics. See Starkage Therapeutics company profile and funding data.See details»
Our Approach - StarkAge Therapeutics
[email protected] +33 3 74 02 03 03; Toggle menu. Our Company. Senior Management; Scientific Advisory Board; Our Approach; News; Contact; Our objective is the development of …See details»
StarkAge Therapeutics - Overview, News & Similar companies
Who is StarkAge Therapeutics. StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of lif e of patients …See details»
Société STARKAGE THERAPEUTICS : Chiffre d'affaires, statuts
Jan 7, 2025 STARKAGE THERAPEUTICS à LILLE (59800) : Bilans, statuts, chiffre d'affaires, dirigeants, actionnaires, levées de fonds, annonces légales, APE, NAF, TVA, RCS, SIREN ...See details»
StarkAge Therapeutics Immunotherapy Against Senescence
[email protected] +33 3 74 02 03 03 www.StarkAgeTX.com Dr. Pierre-Michel Bringer, CEO [email protected] Contacts StarkAge Therapeutics | Corporate …See details»
StarkAge (company) | Nordic 9
StarkAge (company). StarkAge Therapeutics is a biotechnology startup in Frabnce focused on delaying or stopping disease progression and improving the quality of life of patients with age …See details»
Contact - StarkAge Therapeutics
[email protected] +33 3 74 02 03 03; Toggle menu. Our Company. Senior Management; Scientific Advisory Board; Our Approach; News; Contact; Contact. Home StarkAge …See details»
StarkAge Therapeutics - VentureRadar
Website: https://starkagetx.com/ Develops therapies to delay or halt age-related diseases by selectively destroying senescent cells using an innovative immunotherapy ...See details»
StarkAge Therapeutics: a unique and relentless focus on senescence
StarkAge Therapeutics (SATx) is a pioneering privately held discovery-stage biotechnology company based in Lille, France. It was founded in 2018 by Dr. Thierry Mathieu, with scientific …See details»
StarkAge Therapeutics: a unique and relentless focus on senescence
[email protected] +33 3 74 02 03 03; Toggle menu. Our Company. Senior Management; Scientific Advisory Board; Our Approach; News; Contact; All news . We are sharing here our …See details»